Please Wait
Applying Filters...
menu
    • menu
    DRL-PSE
    News
    Dr Reddy's subsidiary sells, assigns US rights for 3 brands Encore Dermatology

    03 Apr 2019

    // ECONOMIC TIMES

    Promius promotes digital campaign to empower skin condition patients

    05 Nov 2018

    // Beth Snyder Bulik FIERCE PHARMA

    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Perrigo Uk Finco

    23 May 2018

    // PATENT LITIGATION

    Data Compilation
    #PharmaFlow

    Dr Reddy Promius Pharma RM

    Contact Supplier

    Website

    Antibody Engineering

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
    Menu

    Promius Pharma

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr Reddy's subsidiary sells, assigns US rights for 3 brands Encore Dermatology
    Dr Reddy's subsidiary sells, assigns US rights for 3 brands Encore Dermatology

    03 Apr 2019

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-subsidiary-sells-assigns-us-rights-for-3-brands-to-encore-dermatology/articleshow/68683488.cms

    ECONOMIC TIMES
    03 Apr 2019
    Share Share
    Promius promotes digital campaign to empower skin condition patients
    Promius promotes digital campaign to empower skin condition patients

    05 Nov 2018

    // Beth Snyder Bulik FIERCE PHARMA

    https://www.fiercepharma.com/marketing/skin-you-re-promius-promotes-digital-campaign-to-empower-people-range-skin-conditions

    Beth Snyder Bulik FIERCE PHARMA
    05 Nov 2018
    Share Share
    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Perrigo Uk Finco
    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Perrigo Uk Finco

    23 May 2018

    // PATENT LITIGATION

    https://insight.rpxcorp.com/litigation_documents/12926948

    PATENT LITIGATION
    23 May 2018
    Share Share
    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Taro Pharmaceuticals
    Sernivo®(Betamethasone Dipropionate): Promius Pharma v. Taro Pharmaceuticals

    23 May 2018

    // PATENT LITIGATION

    https://www.pharmacompass.com/pdf/news/sernivobetamethasone-dipropionate-promius-pharma-v-taro-pharmaceuticals-1527500767.pdf

    PATENT LITIGATION
    23 May 2018
    Share Share
    Dr. Reddy's and its US. subsidiary Promius announce the filing NDA for migraine
    Dr. Reddy's and its US. subsidiary Promius announce the filing NDA for migraine

    02 Apr 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180402005384/en

    BUSINESSWIRE
    02 Apr 2018
    Share Share
    Promius Pharma's Sernivo approved in US as topical steroid
    Promius Pharma's Sernivo approved in US as topical steroid

    05 Feb 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/promius-pharmas-sernivo-approved-in-us-as-topical-steroid-1455104964.pdf

    FDA
    05 Feb 2016
    Share Share